As we stride further into 2025, the pharmacy industry faces a landscape teeming with challenges and opportunities. From tackling drug ...

The pharmaceutical industry is a critical component of the global economy, impacting public health, national security, and economic stability.

Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic ...

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...

To strengthen its U.S. presence, Roche is building up inventory, ramping up production at three of its U.S. plants and relocating one manufacturing site to the U.S. through a technology transfer, its ...

European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...

They're not just leaders of their industry. Their underlying businesses are also on the verge of enormous growth.

Lexaria Bioscience (LEXX) provides a glucagon-like peptide-1 strategic update following important industry developments reported both by Pfizer ...

The FDA's move stops short of the outright ban that had been floated for in Kennedy's "Make America Healthy Again" platform ...

Eli Lilly ( LLY 1.21%) and Novo Nordisk ( NVO 2.66%) were early leaders in the development of GLP-1 agonists, and dominate the market. Research from MarketsandMarkets suggests that annual global sales ...